Luigi Di Biase, AFS 2022: Peri and post procedural anticoagulation with LAA closure devices
The advantages and challenges of peri and post procedural anticoagulation with LAA closure devices were discussed by Prof. Luigi Di Biase in a short interview with touchCARDIO, at the annual AF Symposium 2022.
The abstract entitled ‘Peri and Post Procedural Anticoagulation with LAA Closure Devices – An Evolving Story’ was presented at the annual AF Symposium, January 13-15, 2022.
- What are the advantages and disadvantages of left atrial appendage (LAA) closure as opposed to the use of direct-acting oral anticoagulants in high-risk patients with atrial fibrillation? (0:15)
- Why is peri-and post-procedural anticoagulants needed with LAA closure devices? (1:19)
- What are the challenges of peri-and post-procedural anticoagulants with LAA closure devices? (2:21)
- What have we learned about optimal peri- and post-procedural anticoagulation in this clinical scenario? (3:18)
- What questions remain unanswered and what further research is needed? (4:28)
Disclosures: Luigi Di Biase has nothing to disclose in relation to this video interview
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Katey Gabrysch.
Filmed as a highlight of AFS 2022.
Click here for more content from Prof. Luigi Di Biase.
Share this Video
Related Videos In Atrial Fibrillation
Bruce Wilkoff, EHRA 2023: The AdaptResponse trial, synchronized left ventricular pacing for heart failure with left bundle branch block
The AdaptResponse trial was designed to assess two methods of restoring resynchronization to the heart in patients with heart failure with left bundle branch block. In this touchCARDIO interview, we speak with Dr Bruce Wilkoff (Cleveland Clinic, Cleveland, OH, USA) to discuss the design of the AdaptResponse trial, the outcomes as well as the clinical […]
Bruce Wilkoff, EHRA 2023: An overview of cardiac resynchronization therapy for patients with heart failure
Cardiac resynchronization therapy is designed to restore the electrical activation in a more natural way in patients with heart failure. In this touchCARDIO interview, we speak with Dr Bruce Wilkoff (Cleveland Clinic, Cleveland, OH, USA) to discuss the treatment paradigm with focus on cardiac resynchronization therapy for patients with heart failure. Bruce Wilkoff presented an […]
Søren Zöga Diederichsen, EHRA 2023: NT-proBNP as a tool for atrial fibrillation screening, post hoc analysis of the LOOP study
Recently it has been shown that NT-proBNP may be a useful tool for finding people with an increased risk of atrial fibrillation and stroke. In this touchCARDIO interview, we speak with Dr Søren Zöga Diederichsen (Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark) to discuss the post hoc analysis of the LOOP study. The abstract entitled ‘Atrial […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!